Dundalk start-up targets $51bn connected medical device market.
Nova Leah, a recent Siliconrepublic.com Start-up of the Week, is to create 78 new jobs as the importance of securing medical equipment reaches new heights following recent cyberattacks.
A spokesman for the company said that 50 of the new roles include engineering and support, and will be Dundalk-based. The remainder will be sales and marketing roles in Boston, where the company has just opened an office.
Founded by CEO Anita Finnegan, Nova Leah specialises in developing expert cybersecurity risk management systems specifically for medical devices.
Initial investors in the company include US venture capital company COSIMO Venture Partners and Enterprise Ireland.
“The recent WannaCry ransomware attack on the UK’s NHS highlights the importance of cybersecurity in the health sector,” Finnegan explained.
“Today’s medical devices incorporate high levels of software and are connected across networks, online or wirelessly,” she added.
Local research produces world-beating technology
Nova Leah’s cloud-based system SelectEvidence is the result of a five-year R&D programme at Dundalk Institute of Technology.
The system is designed to guide medical device manufacturers in the implemention of cybersecurity requirements and best practices over the lifetime of a device, in compliance with US FDA (Food and Drug Administration) recommendations for information security threats and risks during pre-market and post-market activities.